Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 9/20 | 0.34 |
| ▸ | CA2 | P00918 | 9/20 | 0.34 |
| ▸ | CA9 | Q16790 | 8/20 | 0.34 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA7 | P43166 | 3/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.33 |
| ▸ | CA3 | P07451 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA6 | P23280 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3804432 | 0.84 | — | — | |
| SCHEMBL9739299 | 0.80 | DNM1 (0.47) | DNM1ALDH1A1CNR1CNR2OPRM1 | |
| SCHEMBL10071572 | 0.77 | DNM1 (0.43) | DNM1ALDH1A1CNR1CNR2TSHR | |
| Hydrochloric Acid SCHEMBL9277599 | 0.77 | DNM1 (0.39) | DNM1ALDH1A1CNR1CNR2TSHR | |
| SCHEMBL19792764 | 0.76 | DNM1 (0.47) | DNM1ALDH1A1CNR1CNR2TSHR | |
| SCHEMBL1378620 | 0.76 | DNM1 (0.42) | DNM1ALDH1A1CNR1CNR2TSHR | |
| SCHEMBL2623215 | 0.76 | DNM1 (0.47) | DNM1ALDH1A1CNR1CNR2TSHR | |
| SCHEMBL11010126 | 0.76 | DNM1 (0.47) | DNM1ALDH1A1CNR1CNR2TSHR | |
| SCHEMBL10071568 | 0.76 | DNM1 (0.47) | DNM1ALDH1A1CNR1CNR2TSHR | |
| SCHEMBL8081463 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105517991-B | Aryloxyalkylamine derivative, pharmaceutical composition and pharmaceutical application thereof | 奥斯瓦道·克鲁兹基金会 | 2019-06-07 | — | — | CN | claimed |
| CN-108912005-A | Two phenoxy group alkylamine derivatives and its pharmaceutical composition | 奥斯瓦道·克鲁兹基金会 | 2018-11-30 | — | — | CN | claimed |
| CN-105517991-B | Aryloxyalkylamine derivative, pharmaceutical composition and pharmaceutical application thereof | 奥斯瓦道·克鲁兹基金会 | 2019-06-07 | — | — | CN | disclosed |
| CN-105517991-B | Aryloxyalkylamine derivative, pharmaceutical composition and pharmaceutical application thereof | 奥斯瓦道·克鲁兹基金会 | 2019-06-07 | — | — | CN | disclosed |
| CN-105517991-B | Aryloxyalkylamine derivative, pharmaceutical composition and pharmaceutical application thereof | 奥斯瓦道·克鲁兹基金会 | 2019-06-07 | — | — | CN | disclosed |
| CN-108912005-A | Two phenoxy group alkylamine derivatives and its pharmaceutical composition | 奥斯瓦道·克鲁兹基金会 | 2018-11-30 | — | — | CN | disclosed |
| CN-108912005-A | Two phenoxy group alkylamine derivatives and its pharmaceutical composition | 奥斯瓦道·克鲁兹基金会 | 2018-11-30 | — | — | CN | disclosed |
| CN-105712977-A | CYCLOALKYLOXY- AND HETEROCYCLOALKYLOXYPYRIDINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR | 詹森药业有限公司 | 2016-06-29 | — | — | CN | disclosed |
| US-9320752-B2 | Pesticidal ear tag | Y-TEX CORPORATION (US) | 2016-04-26 | — | — | US | disclosed |
| CN-105517991-A | Diphenyloxyalkylamine derivatives and aryloxyalkylamine derivatives, pharmaceutical compositions, use of said pharmaceutical compositions for treating, preventing or inhibiting chronic pulmonary inflammatory diseases and methods for treating or preventing said diseases | FUNDACAO OSWALDO CRUZ | 2016-04-20 | — | — | CN | disclosed |
| US-20130273134-A1 | PESTICIDAL EAR TAG | Y-TEX CORPORATION | 2013-10-17 | — | — | US | disclosed |
| WO-2004113305-A2 | DIAMINO SUBSTITUTED QUINAZOLINE DERIVATIVES AS PROMOTERS OF SMN2 | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2004-12-29 | — | — | WO | disclosed |
| EP-0969065-B1 | Die attach adhesives for use in microelectronic | NAT STARCH CHEM INVEST (US) | 2004-10-06 | — | — | EP | disclosed |
| CN-1468227-A | Non-imidazole aryloxyalkylamines | ����-������ҩƷ��˾ | 2004-01-14 | — | — | CN | disclosed |
| US-6355750-B1 | CURABLE ADHESIVE COMPRISING SILOXANE-CONTAINING MALEIMIDE COMPOUND AND FREE RADICAL- OR PHOTOINITIATOR; SEMICONDUCTORS, INTEGRATED CIRCUITS | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2002-03-12 | — | — | US | disclosed |
| US-20020007042-A1 | Die attach adhesives for use in microelectronic devices | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2002-01-17 | — | — | US | disclosed |
| EP-1146065-A1 | Die attach adhesives for use in microelectronic devices | National Starch and Chemical Investment Holding Corporation (US) | 2001-10-17 | — | — | EP | disclosed |
| US-6265530-B1 | CURABLE ADHESIVE COMPOSITION FOR BONDING ELECTRONIC COMPONENT TO SUBSTRATE COMPRISING MALEIMIDE COMPOUND AND CURING INITIATOR SELECTED FROM GROUP CONSISTING OF FREE RADICAL INITIATOR, PHOTOINITIATOR AND COMBINATION THEREOF | NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION | 2001-07-24 | — | — | US | disclosed |
| EP-0969065-A2 | Die attach adhesives for use in microelectronic | National Starch and Chemical Investment Holding Corporation (US) | 2000-01-05 | — | — | EP | disclosed |
| WO-1990010628-A1 | NOVEL ARYLOXY ALKYL AMINES, THEIR PRODUCTION AND MEDICAMENTS CONTAINING THEM | LAEVOSAN-GESELLSCHAFT MBH (AT) | 1990-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130273134-A1 | PESTICIDAL EAR TAG | ABAT, AADAC, BRDT | DNM1 856/4885ALDH1A1 1223/4885CNR1 3640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.